Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
LONGER-TERM EXPERIENCE WITH TENOFOVIR ALAFENAMIDE (TAF) IN HBV-INFECTED PATIENTS; CHANGES IN EGFR, FIB4, ALT, AND DNA SUPPRESSION Reddy, K., Curry, M. P., Bae, H. S., Dieterich, D. T., Ankoma-Sey, V., Pan, C. Q., Hann, H. L., Tong, M. J., Kim, W., Kwo, P., Frazier, L., Cox, K., Milligan, S., Afdhal, N. H. WILEY. 2019: 309A
View details for Web of Science ID 000488653501053